Last reviewed · How we verify
NCT03187613
Correlation of Metamorphopsia and Aniseikonia to Retinal Shift Following Retinal Detachment Surgery
trial in Retinal Detachment in 38 participants. Completed in 31 December 2020.
31 December 2020
Quick facts
| Lead sponsor | Helse Stavanger HF |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 38 |
| Start date | 21 June 2017 |
| Primary completion | 31 December 2020 |
| Estimated completion | 31 December 2020 |
| Sites | 1 location across Norway |
Conditions studied
- Retinal Detachment — all drugs for Retinal Detachment →
Sponsor
Helse Stavanger HF — full company profile →
Who can join
18 and older, any sex, with Retinal Detachment. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Individuals operated for rhegmatogenous retinal detachment will be prospectively evaluated for postoperative retinal shift. Fundus autofluorescence will be used to evaluate retinal shift that will be correlated to visual acuity, metamorphopsia, aniseikonia, and stereopsis.
Publications & conference data
2 peer-reviewed publications reference this trial (live from Europe PMC):
-
Displacement of the retina in the late follow-up after retinal detachment repair.
Thomseth VM, Roditi E, Brosh K, Potter MJ, et al · · 2025 · PMID 40952487 · DOI 10.1007/s00417-025-06892-9 -
Reticular Pseudodrusen Voids after Rhegmatogenous Retinal Detachment.
Forsaa VA, Thomseth VM. · · 2023 · PMID 37901649 · DOI 10.1159/000531676
Verify or expand the search:
- PubMed search for NCT03187613
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Retinal Detachment
Currently open trials in the same condition.
- NCT06587945 — Nicotinamide Riboside Oral Supplementation in Macula Off Retinal Detachment · Phase 4 · recruiting
- NCT06985030 — Head Position Monitoring After Pars Planar Vitrectomy · active not recruiting
- NCT06830070 — Subjective Pain Scoring for Subtenonal Anesthesia During Vitrectomy · active not recruiting
- NCT03713268 — Intraoperative OCT Guidance of Intraocular Surgery II · recruiting
Other Helse Stavanger HF trials
Trials by the same sponsor.
- NCT06983002 — Bridging Affect Consciousness, Mentalization and Trauma- Exploring an Integrative Treatment Approach for Personality Dis · NA · not yet recruiting
- NCT06774261 — Phenserine on the Alzheimer's Treatment Horizon, Study 1 · Phase 1 · not yet recruiting
- NCT06362707 — Fasudil Trial for Treatment of Early Alzheimer's Disease (FEAD) · Phase 2 · recruiting
- NCT06211907 — Small Macular Holes Treated With Air · NA · recruiting
- NCT06150274 — Comparison of Wire Assisted Percutaneous Balloon Mitral Valvulotomy With Standard Inoue Balloon Valvulotomy · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03187613 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Helse Stavanger HF
- Last refreshed: 28 September 2021
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03187613.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing